Greenbrook TMS Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GTMS.TO research report →
Companywww.greenbrooktms.com
Greenbrook TMS Inc. , together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services.
- CEO
- William P. Leonard
- IPO
- 2018
- Employees
- 644
- HQ
- Toronto, ON, CA
Valuation
- Market Cap
- $28.55M
- P/E
- -0.03
- P/S
- 0.08
- P/B
- -0.10
- EV/EBITDA
- -5.59
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 8.77%
- Op Margin
- -42.60%
- Net Margin
- -125.48%
- ROE
- 1574.36%
- ROIC
- -38.26%
Growth & Income
- Revenue
- $69.10M · 32.39%
- Net Income
- $-86,713,255 · -193.81%
- EPS
- $-3.12 · -63.35%
- Op Income
- $-28,725,796
- FCF YoY
- 19.09%
Performance & Tape
- 52W High
- $7.65
- 52W Low
- $0.97
- 50D MA
- $2.51
- 200D MA
- $3.08
- Beta
- 1.79
- Avg Volume
- 9.04K
Get TickerSpark's AI analysis on GTMS.TO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GTMS.TO Coverage
We haven't published any research on GTMS.TO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GTMS.TO Report →